If you have diabetes, it's crucial to watch your diet and choose your drinks wisely. While teas might seem like a healthy ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side effects.

Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...